_version_ 1784596402912886784
author Marzolini, Maria A. V.
Mehra, Varun
Thomson, Kirsty J.
Tholouli, Eleni
Bloor, Adrian J. C.
Parker, Anne
Lovell, Richard
Orchard, Kim
Publicover, Amy
Nicholson, Emma
Snowden, John A.
Byrne, Jennifer
Khan, Anjum
Gilleece, Maria H.
Errico, Gerardo
Lozano, Sara
Hurst, Erin
Duncan, Nick
Pirrie, Jennifer
Crea, Philip
Carpenter, Ben
Pagliuca, Antonio
Peggs, Karl S.
author_facet Marzolini, Maria A. V.
Mehra, Varun
Thomson, Kirsty J.
Tholouli, Eleni
Bloor, Adrian J. C.
Parker, Anne
Lovell, Richard
Orchard, Kim
Publicover, Amy
Nicholson, Emma
Snowden, John A.
Byrne, Jennifer
Khan, Anjum
Gilleece, Maria H.
Errico, Gerardo
Lozano, Sara
Hurst, Erin
Duncan, Nick
Pirrie, Jennifer
Crea, Philip
Carpenter, Ben
Pagliuca, Antonio
Peggs, Karl S.
author_sort Marzolini, Maria A. V.
collection PubMed
description
format Online
Article
Text
id pubmed-8579255
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-85792552021-11-10 Letermovir prophylaxis in T-cell–depleted transplants: breakthrough and rebound infections in the postmarketing setting Marzolini, Maria A. V. Mehra, Varun Thomson, Kirsty J. Tholouli, Eleni Bloor, Adrian J. C. Parker, Anne Lovell, Richard Orchard, Kim Publicover, Amy Nicholson, Emma Snowden, John A. Byrne, Jennifer Khan, Anjum Gilleece, Maria H. Errico, Gerardo Lozano, Sara Hurst, Erin Duncan, Nick Pirrie, Jennifer Crea, Philip Carpenter, Ben Pagliuca, Antonio Peggs, Karl S. Blood Adv Research Letter American Society of Hematology 2021-11-09 /pmc/articles/PMC8579255/ /pubmed/34614515 http://dx.doi.org/10.1182/bloodadvances.2021005637 Text en © 2021 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
spellingShingle Research Letter
Marzolini, Maria A. V.
Mehra, Varun
Thomson, Kirsty J.
Tholouli, Eleni
Bloor, Adrian J. C.
Parker, Anne
Lovell, Richard
Orchard, Kim
Publicover, Amy
Nicholson, Emma
Snowden, John A.
Byrne, Jennifer
Khan, Anjum
Gilleece, Maria H.
Errico, Gerardo
Lozano, Sara
Hurst, Erin
Duncan, Nick
Pirrie, Jennifer
Crea, Philip
Carpenter, Ben
Pagliuca, Antonio
Peggs, Karl S.
Letermovir prophylaxis in T-cell–depleted transplants: breakthrough and rebound infections in the postmarketing setting
title Letermovir prophylaxis in T-cell–depleted transplants: breakthrough and rebound infections in the postmarketing setting
title_full Letermovir prophylaxis in T-cell–depleted transplants: breakthrough and rebound infections in the postmarketing setting
title_fullStr Letermovir prophylaxis in T-cell–depleted transplants: breakthrough and rebound infections in the postmarketing setting
title_full_unstemmed Letermovir prophylaxis in T-cell–depleted transplants: breakthrough and rebound infections in the postmarketing setting
title_short Letermovir prophylaxis in T-cell–depleted transplants: breakthrough and rebound infections in the postmarketing setting
title_sort letermovir prophylaxis in t-cell–depleted transplants: breakthrough and rebound infections in the postmarketing setting
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579255/
https://www.ncbi.nlm.nih.gov/pubmed/34614515
http://dx.doi.org/10.1182/bloodadvances.2021005637
work_keys_str_mv AT marzolinimariaav letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting
AT mehravarun letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting
AT thomsonkirstyj letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting
AT tholoulieleni letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting
AT blooradrianjc letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting
AT parkeranne letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting
AT lovellrichard letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting
AT orchardkim letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting
AT publicoveramy letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting
AT nicholsonemma letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting
AT snowdenjohna letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting
AT byrnejennifer letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting
AT khananjum letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting
AT gilleecemariah letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting
AT erricogerardo letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting
AT lozanosara letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting
AT hursterin letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting
AT duncannick letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting
AT pirriejennifer letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting
AT creaphilip letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting
AT carpenterben letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting
AT pagliucaantonio letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting
AT peggskarls letermovirprophylaxisintcelldepletedtransplantsbreakthroughandreboundinfectionsinthepostmarketingsetting